MedTrace Logo

Nutraceuticals and Vascular Remodelling

NCT04433429 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2020-06-16

No results posted yet for this study

Summary

Aim of the study is to assess the effect of a long-term nutraceutical multitarget approach on lipid profile, inflammatory mediators and vascular remodeling in primary cardiovascular prevention in a setting of controlled dietary habits. The nutraceutical combination used in this study consists of a single pill containing 333 mg of RYR, equivalent to 10 mg of Monacolin K, and 30 mg of Coenzyme Q10 (CoQ10).

Conditions

Interventions

DIETARY_SUPPLEMENT

Liposcudil Plus

Sponsors & Collaborators

  • Marcello Rattazzi

    lead OTHER

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04433429 on ClinicalTrials.gov